Objective: An automated cognitive neurophysiological test is presented that characterizes how an individual was affected by a drug or treatment. The test calculates sub-scores for working memory task performance, cortical activation, and alertness, and combines the sub-scores into an overall score. Methods: The test was applied in a double-blind, placebo-controlled study of alcohol, caffeine, diphenhydramine, and sleep deprivation in 16 healthy adults. Results: The between-and within-day variability of the sub-scores and overall scores for placebo were all near zero, suggesting that the scores are stable. All treatments affected the overall score, while differential effects on sub-scores highlighted the added value of EEG measures. Conclusions: The test is sensitive to relatively mild alterations in cognitive function. Its automation makes it suitable for use in large-scale clinical trials. Significance: By combining task performance with EEG brain function measures, the test may prove to have better sensitivity and specificity in detecting changes due to drugs or other treatments than comparable neuropsychological test batteries that do not directly measure brain function signals.
Introduction
Cognitive brain function is affected by many diseases, by the intended and unintended effects of treatment medications, and by a variety of stressors such as disturbed sleep. There are many batteries for assessing cognition based on performance on tests of cognitive function and rating scales. However, behavior is the end product of many neural systems, some of which may be recruited or adapted in some way to compensate for deficits. For instance, a motivated impaired person may make a greater effort and not show signs of impairment, and a person who is simply drowsy may have a poor cognitive test score but not have a disease affecting cognitive brain function per se. Tests that do not directly measure brain function signals have difficulty accounting for factors such as motivation and alertness, and therefore have limited sensitivity and specificity.
The lack of a clinical standard for testing cognitive brain function has been cited as a major confounding factor in the discrepancies between the results of different clinical trials (Vermeulen and Aldenkamp, 1995) . Standardized neurologically based tests of an individual's cognitive brain function have the potential to make such evaluations more sensitive and efficient, and could be helpful to researchers, clinicians, and patients. Towards this goal, we present an automated cognitive neurophysiological test, the Sustained Working Memory Test (SWMT) that combines cognitive test performance measures with EEG measures. The multivariate analysis combines task response accuracy and speed measures with taskrelated and resting EEG measures to arrive at an assessment of how an experimental drug or stressor, or a disease and its treatment, has changed an individual's neurocognitive functional status. This paper focuses on the initial version of the SWMT that assesses treatment-related changes relative to an individual's placebo or pre-treatment baseline test.
Working memory, EEG and the scientific basis of the SWMT
Working memory (WM) is the fundamental cognitive function of controlling attention and actively sustaining its focus on a particular mental representation (Baddeley, 1992; Engle et al., 1999) . It is essential for reasoning, planning, learning, and other higher cognitive functions, and is highly correlated with performance on psychometric tests of cognitive ability such as IQ tests (Carpenter et al., 1990; Gevins and Smith, 2000; Kyllonen and Christal, 1990 
